Project: Innovative Multifaceted Platform for Antimicrobials Commercialisation Transformation 2

Acronym IMPACT2 (Reference Number: 12589)
Duration 01/09/2018
Project Topic BioVersys (BV), BioSystems Technology (BST) and Voxcan (VX) will produce a solution to transform antimicrobial drug discovery through a seamless platform for effective in vitro and real-time in vivo drug candidate screening and target validation. It will reduce drug candidate failures by streamlining pre-clinical evaluation directly in clinically relevant strains prior to testing candidates in expensive and time-consuming mammalian infection models, bridging the pharmaceutical "Valley of Death".
Network Eurostars 2
Call Eurostars Cut–off 9

Project partner

Number Name Role Country
1 BioVersys Coordinator Switzerland
2 BioSystems Technology Partner United Kingdom
3 Voxcan Partner France